000			01559nam a2200181 4500
003			OSt
005			20250114112612.0
008			250114b |||||||| |||| 00| 0 eng d
100			_aGanga Srinivasan
245			_aCANNABIS-DERIVED PHARMACEUTICAL PRODUCTS: THERAPEUTIC, PHARMACOKINETIC AND CLINICAL IMPLICATIONS - A COMPREHENSIVE REVIEW
300			_aP.7-20
520			_a Cannabis, a diverse compounded plant with a rich cultural and scientific history, has garnered significant attention due to its therapeutic and medicinal potential. The plant’s main active compounds, phytocannabinoids, notably Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), play important roles in its effects. Cannabis formulations range from traditional herbal preparations to modern innovations like edibles, sprays, topicals and vaporizable products. Achieving consistent potency, controlled release, and desirable pharmacokinetics remain a challenge. The article delves into its diverse formulations obtained along with its routes of administration. The article provides an overview of cannabinoids-based formulations, highlighting their significance in the context of emerging therapeutic and commercial opportunities, while acknowledging the need for further research to optimize formulations and maximize benefits.
654			_aCannabis _acannabinoids _aCBD _aTHC _aECS
700			_a Deepak Shukla
773	0		_0125265 _9111177 _dMumbai Indian Drugs Manufacturer's Association _oJP490 _tIndian Drugs _x0019-462X
942			_cJA
942			_2ddc
999			_c130733 _d130733